FOLR1 and breast carcinoma: MOv18-SB-A-419259 exerted a concentration-dependent decrease in tumour cell viability in the FRα overexpressing CAL51 basal breast cancer cells while unconjugated MOv18 antibody or payload A-419259 alone had no impact on cell viability (Fig. 2d, left panel).